Company
Hemex Health
Gazelle Delivers Quantitative, Clinically Actionable Results at the Point of Care
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Founded
- 2016
- Customers
- health care providers in over 40 countries. Gazelle is sold through full-service medical distributors.
- Legal name
- Hemex Health, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
The Gazelle diagnostic platform by Hemex Health detects and quantifies important blood-based conditions—from inherited disorders like sickle cell disease and beta thalassemia to iron-related and chronic conditions.
Funding snapshot
- Total raised
- $3.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round2018-01-26
Funding rounds
- Round, 2018
- 2018-01-261 investor
- Round, 2018
- $930K2018-01-19, SEC form D sold, 27 investors
- Round, 2016
- $3M2016-09-26, SEC form D sold, 46 investors
Products
- Hardware
- Gazelle
Loading relationship preview